The cbl oncogene: a novel substrate of protein tyrosine kinases - PubMed (original) (raw)

Review

The cbl oncogene: a novel substrate of protein tyrosine kinases

W Y Langdon. Aust N Z J Med. 1995 Dec.

Abstract

The cbl oncogene was first identified as part of a transforming retrovirus which arose in a mouse pre-B cell lymphoma. Its protein product, p120cbl, is cytoplasmic and has several distinctive domains including a highly basic region, a RING finger motif and a large proline-rich domain. A mutation to cbl in the 70Z/3 pre-B cell lymphoma produces an oncogenic protein which exhibits a marked enhancement of tyrosine phosphorylation. Parallel studies have demonstrated that p120cbl is a substrate of protein Tyrosine kinases activated by engagement of the T cell antigen receptor and that cbl is phosphorylated by oncogenic forms of the Abl tyrosine kinase. These studies also demonstrated a constitutive association between cbl and the SHS domains of the Grb2 and Nck adaptor proteins in a range of haemopoietic cell lines. More recently it has been found that cbl is rapidly phosphorylated following stimulation of the EGF receptor, Fcy receptor, c-Kit receptor and CSF-1 receptor. A genetic analysis in Caenorhabditis elegans has identified a cbl homologue, called sli-1, that negatively regulates the LET-23 tyrosine kinase receptor. These characteristics indicate a central role for cbl in the regulation of intracellular signals that are mediated by growth factors and antigenic stimuli which activate protein tyrosine kinases.

PubMed Disclaimer

Cited by

Abnormal regulation of BCR signalling by c-Cbl in chronic lymphocytic leukaemia.
Martini V, Frezzato F, Severin F, Raggi F, Trimarco V, Martinello L, Molfetta R, Visentin A, Facco M, Semenzato G, Paolini R, Trentin L. Martini V, et al. Oncotarget. 2018 Aug 14;9(63):32219-32231. doi: 10.18632/oncotarget.25951. eCollection 2018 Aug 14. Oncotarget. 2018. PMID: 30181811 Free PMC article.
Altered thymic positive selection and intracellular signals in Cbl-deficient mice.
Naramura M, Kole HK, Hu RJ, Gu H. Naramura M, et al. Proc Natl Acad Sci U S A. 1998 Dec 22;95(26):15547-52. doi: 10.1073/pnas.95.26.15547. Proc Natl Acad Sci U S A. 1998. PMID: 9861006 Free PMC article.
Role of phosphoinositide 3-kinase and the Cbl adaptor protein in coupling the alpha4beta1 integrin to mitogen-activated protein kinase signalling.
Finkelstein LD, Shimizu Y. Finkelstein LD, et al. Biochem J. 2000 Jan 15;345 Pt 2(Pt 2):385-92. Biochem J. 2000. PMID: 10620516 Free PMC article.
Spatial determinants of specificity in insulin action.
Mastick CC, Brady MJ, Printen JA, Ribon V, Saltiel AR. Mastick CC, et al. Mol Cell Biochem. 1998 May;182(1-2):65-71. Mol Cell Biochem. 1998. PMID: 9609115 Review.

The cbl oncogene: a novel substrate of protein tyrosine kinases - PubMed (original) (raw)